8-K: Tharimmune Raises $55M for Digital Asset Strategy

Sentiment:

Equity Offering 22 January 2026 4:12 PM

Tharimmune, Inc. closed a $55 million underwritten registered direct offering to fund its Canton-centric digital asset treasury strategy and general corporate purposes.

Capital raiseThe company completed an underwritten registered direct offering, issuing 1,800,000 shares of common stock and pre-funded warrants to purchase up to 17,000,000 shares of common stock.The offering generated approximately $55 million in gross proceeds.The proceeds are earmarked for the expansion of its Canton-centric digital asset treasury strategy and general corporate purposes.This offering follows a previously disclosed ATM Program, which had raised $7,147,829 as of January 16, 2026, before one of its agents terminated its role.

Summary

Tharimmune, Inc. completed an underwritten registered direct offering, raising approximately $55 million in gross proceeds.
The offering included 1,800,000 shares of common stock at $2.92 per share and pre-funded warrants to purchase up to 17,000,000 shares of common stock at $2.9199 per warrant.
The pre-funded warrants have a nominal exercise price of $0.0001 per share, are immediately exercisable, and do not expire.
Proceeds will primarily support the expansion and development of the company's Canton-centric digital asset treasury strategy and general corporate purposes.
The company also disclosed that its ATM Program, initiated on November 6, 2025, had generated $7,147,829 in gross proceeds as of January 16, 2026, with President Street Global, LLC terminating its agent role on December 3, 2025.

Sentiment

Score: 7

Explanation: The capital raise provides significant funding for the company's stated strategic direction in digital assets, which is a positive. However, the substantial potential dilution from the warrants and the termination of an ATM program agent introduce some caution. The focus on a specific blockchain network (Canton) could be a high-growth opportunity but also carries concentration risk.

Positives

Successfully raised approximately $55 million in gross proceeds, providing significant capital for strategic initiatives and working capital.
The capital infusion supports the expansion of the Canton-centric digital asset treasury strategy, indicating commitment to a growth area.
Pre-funded warrants offer flexibility to investors with a nominal exercise price and no expiration.

Negatives

The offering involves the issuance of a substantial number of shares and warrants (1,800,000 shares + 17,000,000 warrant shares), which could lead to significant dilution for existing shareholders.
One of the agents (President Street Global, LLC) for the previously disclosed ATM Program terminated its role, which might indicate challenges with that program.

Risks

Forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside the company's control, that could cause actual results or outcomes to differ materially.
Investors are cautioned to carefully consider factors and risks described in the Risk Factors sections of the company's SEC filings.
The beneficial ownership limitation on warrant exercise (initially 4.99%, adjustable to 19.99%) could restrict immediate full exercise by a large holder.
Potential for dilution from the exercise of the pre-funded warrants.

Future Outlook

The company intends to use the proceeds primarily for the continued expansion and development of its Canton-centric digital asset treasury strategy, as well as for working capital and general corporate purposes. This indicates a strategic focus on institutional blockchain adoption and the digitization of financial markets.

Management Comments

Tharimmune, Inc. operates a differentiated digital asset treasury strategy by actively participating in the Canton Network – a privacy-enabled, secure blockchain hosting trillions in assets on chain.

Industry Context

Tharimmune, Inc. positions itself as the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets. This places the company at the intersection of traditional finance and blockchain technology, specifically focusing on institutional adoption of digital assets. The Canton Network is described as a privacy-enabled, secure blockchain hosting trillions in assets on chain, suggesting a focus on enterprise-grade blockchain solutions. The company also maintains clinical-stage biotech research and development, indicating a diversified business model.

Comparison to Industry Standards

The filing does not provide specific comparable companies, projects, or results to assess the offering in the context of global benchmarks.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Compliance Commitment	The company has agreed to comply with all applicable corporate governance requirements set forth in the Exchange's listing rules.	2026-01-20	Ensures adherence to regulatory standards for listed companies.
Lock-Up Agreement	The company is subject to a 60-day lock-up period on issuing additional securities, with exceptions for existing plans, conversions, and M&A/JV/strategic alliances up to 5% of outstanding shares.	2026-01-20	Aims to stabilize the stock price post-offering by limiting immediate supply, with carve-outs for strategic flexibility.
Right of First Refusal	Clear Street LLC, the underwriter, has an irrevocable right of first refusal for 12 months for future equity and debt offerings of the company.	2026-01-20	Grants the underwriter preferential access to future capital raising activities, potentially streamlining future financings but limiting the company's choice of bankers.

Legal Proceedings

The company represents that there are no legal or governmental proceedings that would have a Material Adverse Effect, except as disclosed in the General Disclosure Package (not provided in full in this filing).
No corporate integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with governmental or regulatory authority are in place.
No exclusion, suspension, or debarment from U.S. federal health care programs or human clinical research has occurred.

Stakeholder Impact

Shareholders: Potential dilution from the issuance of new common stock and the exercise of pre-funded warrants. However, the capital raise supports strategic growth initiatives which could create long-term value.
Investors (new): Opportunity to invest in the company's digital asset strategy at the offering price.
Company: Strengthened financial position with $55 million in gross proceeds for strategic growth and working capital.
Underwriter (Clear Street LLC): Earns underwriting discounts and commissions, and secures a right of first refusal for future offerings.

Next Steps

Continued expansion and development of the Canton-centric digital asset treasury strategy.
General corporate purposes and working capital.
Listing of the Common Shares and Warrant Shares on The Nasdaq Stock Market LLC.

Key Dates

Date	Description
2025-11-06	Company entered into an ATM Sales Agreement.
2025-12-03	President Street Global, LLC provided notice to terminate its role as an Agent in the ATM Program.
2026-01-09	Shelf registration statement on Form S-3 filed with the SEC.
2026-01-16	Shelf registration statement became effective. Also, as of this date, the company received $7,147,829 in gross offering proceeds from the ATM Program.
2026-01-20	Date of earliest event reported; Company entered into an underwriting agreement for the offering; Prospectus supplement filed with the SEC.
2026-01-21	Expected Closing Date for the offering.
2026-01-22	Press release issued announcing the closing of the offering.

Recommendation

hold

The capital raise is a positive for Tharimmune, providing substantial funding for its digital asset strategy and general operations. The focus on the Canton Network and institutional blockchain adoption presents a potentially high-growth area. However, the significant dilution from the offering, coupled with the termination of an agent in a prior ATM program, introduces uncertainty. Without more detailed financial performance data or specific project milestones related to the Canton strategy, a 'hold' recommendation is prudent. Investors should monitor the execution of the digital asset strategy and the impact of dilution on per-share metrics.

Keywords

Tharimmune, THAR, Underwritten Offering, Pre-Funded Warrants, Capital Raise, Digital Assets, Canton Network, Blockchain, Financial Markets, SEC Filing, Equity Offering, Warrants, Nasdaq

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.